Berkeley Lights is a Digital Cell Biology company focused on enabling and accelerating the development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for single cells in parallel and can also deliver the live biology customers desire in the form of the cells. Co.'s platform captures and interprets the qualitative language of biology and translates it into single-cell specific digital information, referred to as Digital Cell Biology. Co. is focused on the markets of antibody therapeutics, cell therapy and synthetic biology with its platform. The BLI stock yearly return is shown above.
The yearly return on the BLI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the BLI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|